TQ Quiz | Innovations in Clinical Practice (Scottsdale 2025) by Events@optometricedu.com | Jan 26, 2025 | 2025 Scottsdale, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 60 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. What percentage of cataract eyes are on ocular hypertensive medications?* A. 10% B. 20% C. 30% D. 40% 2. A travoprost intraocular implant showed average IOP reductions in a fast and slow-release elution arms of:* A. 8.3 and 8.5 B. 6.3 and 6.5 C. 4.3 and 4.5 D. 10.3 and 10.5 3. In the “Rationale for the COAST Trial” the 10-year results of medication free rates for the low-energy SLT group was:* A. 78.3% B. 13.5% C. 58.3% D. 25% 4. A device that places three (3) trabecular microbypass stents is approved to be used:* A. Only in combination with cataract surgery B. As a standalone procedure C. Only in mild glaucoma D. Only in pigmentary glaucoma 5. In a 24 month Phase I/II clinical trial involving the bimatoprost pellet the no rescue or retreatment percent in the 10 microgram group was _____% at 12 months:* A. 90% B. 40% C. 25% D. 10% 6. Which IOL technology allows IOL modifications using UV light?* A. Light adjustable lens B. Trifocal IOL C. Extended depth of focus IOL D. Pinhole IOL 7. In current available intraocular lenses (IOLs) for near vision, the most near add is given by:* A. EDOF lenses B. Accommodating lenses C. Trifocal lenses D. Multifocal lenses 8. ______ of patients present with > 0.75 D of cylinder prior to cataract surgery.* A. 32.6% B. 42.6% C. 52.6% D. 62.6% 9. _____________ is an angiotensin II receptor blocker (ARB) that's used off-label to treat corneal scarring caused by myofibroblasts:* A. Losartan B. Loteprednol C. Amniotic membranes D. Cenergermin 10. Which of the following treatments is not a standard of care for treating corneal graft rejection?* A. Topical steroids B. K-Pro C. Pilocarpine D. Repeat PK 11. Indications for descemet’s stripping only (DSO) include all of the following except:* A. Presence of central guttae B. Clear peripheral cornea with an endothelial cell count > 1000 cells/mm2 on confocal or specular microscopy C. Phakic or pseudophakic D. Corneal thickness >600 microns 12. _______ is elevated in seasonal, perennial, atopic, vernal and giant papillary conjunctivitis?* A. IgE B. Lactoferrin C. Tear osmolarity D. MMP-9 13. Amniotic membranes have all of the properties except?* A. Anti-inflammatory B. Anti-angiogenic C. Anti-scarring D. Anti-pyretic 14. What is the pH of perfluorohexyloctane?* A. 5.5 B. 7.0 C. 8.0 D. No ph due to no water 15. Which of the following agents targets, paralyzes and eradicates Demodex mites as its mechanism of action?* A. AZR-MD-001 B. NOV03 C. Reproxolap D. TP-03 16. All of the following are ways to test for corneal sensitivity except?* A. Cochet Bonnet B. Cotton tipped applicator C. Non-invasive air pulse D. Tactile IOP 17. _________ is the human ability to perceive small differences in the relative spatial localization of two objects in space.* A. Preferential hyperacuity B. Fixation disparity C. Neuroadaptation D. Neuroplasticity 18. How long does sulfur hexafluoride (SF6) last as a tamponade agent?* A. 1 week B. 2 weeks C. 1 month D. 2 months 19. Modern vitrectomies _______________* A. Requires extensive suturing B. Rarely requires sutures C. Require months of face down rest D. Require more than one oral medication 20. All of the following are treatments for geographic atrophy except?* A. Low vision aids B. Pegcetacoplan C. Avacincaptad pegol D. Focal laser Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeScottsdale 2025 - Innovations in Clinical Practice*After 90 days, pricing will increase to $30. Price: (Past 90 Days) Scottsdale 2025 - Innovations in Clinical PracticeThis course was presented over 90 days ago. Due to this late submission of TQ, your TQ credit price is $30. Price: Retake Discount Price: Promotional Discount Price: (Past 60 Days) Retake Discount Price: (Past 60 Days) Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
